Mar 14, 2024 · The New Drug Application (NDA) for imetelstat for the treatment of transfusion-dependent anemia in patients with lower-risk myelodysplastic ...
People also ask
What is the drug for geron blood disorder?
What is the new drug for MDS?
Is imetelstat fda approved?
Is geron stock a buy?
We plan to partner with patients, care partners, physicians and payers to provide safe, effective and innovative medications to fight blood cancers, with the ...
Aug 21, 2023 · Geron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS. August 21, 2023. Download (opens in ...
IMpress is a Phase 2 clinical trial evaluating imetelstat as a single agent in patients with acute myeloid leukemia (AML) or high-risk MDS, who are relapsed/ ...
Mar 15, 2024 · FDA committee back Geron's blood disorder drug. The committee ultimately backed the benefits of imetelstat based on data from the Phase III ...
Mar 12, 2024 · Geron is seeking approval of the injectable drug, called imetelstat, for treating transfusion-dependent anemia in patients with a group of blood ...
Jun 21, 2023 · A new drug application (NDA) for imetelstat, a telomerase inhibitor used to treat transfusion-dependent anemia in patients with low- to ...
Mar 14, 2024 · TD anemia due to LR MDS is debilitating to patient outcomes and lifestyle. ▫ Only 2 products (luspatercept, lenalidomide) approved post-ESA.
Mar 14, 2024 · Geron Announces FDA Oncologic Drugs Advisory ... Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS ... therapies with the ...
We share a deep-rooted commitment to bringing the potential power of telomerase inhibition to patients. · Clinical trials · About Myelodysplastic Syndromes (MDS).